Experimental Drug Shows Promise Against Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.Affecting as many as 1.5 million people in the United States, lupus is an autoimmune …
Learn MoreAHA News: Her Research Is Getting Worldwide Attention. But For Now, She Needs to Finish High School.
THURSDAY, Sept. 8, 2022 (American Heart Association News) — Explaining her research, Maria Balhara sounds like a typical scientist: She had a hypothesis. She recruited participants to evaluate. She analyzed the data. Soon, she’ll present her work at …
Learn MoreAHA News: Her Research Is Getting Worldwide Attention. But For Now, She Needs to Finish High School.
THURSDAY, Sept. 8, 2022 (American Heart Association News) — Explaining her research, Maria Balhara sounds like a typical scientist: She had a hypothesis. She recruited participants to evaluate. She analyzed the data. Soon, she’ll present her work at …
Learn MoreDoctors ‘Concerned’ About Health of Queen Elizabeth II
THURSDAY, Sept. 8, 2022 (HealthDay News) — Buckingham Palace on Thursday announced that Britain’s Queen Elizabeth II has been placed under medical supervision following “concern” from her doctors over her health. The queen, 96, is still residing at B…
Learn MoreToo Little Exercise, Too Much Sitting Could Raise Breast Cancer Risk
THURSDAY, Sept. 8, 2022 (HealthDay News) — Sitting on the couch or behind a desk could be increasing your risk of breast cancer, a new genetics-driven study suggests.People more likely to engage in physical activity based on their DNA had a 41% lower…
Learn MoreNurse Practitioners Are Filling the Gap in U.S. Psychiatric Care
THURSDAY, Sept. 8, 2022 (HealthDay News) — While mental health care has become a full-blown crisis in the United States, a new study finds that psychiatric nurse practitioners are helping to fill the gap. The researchers discovered that the mental he…
Learn MoreIn Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its ad…
Learn MoreVitamin D Supplements Won’t Shield You From COVID-19, Studies Find
THURSDAY, Sept. 8, 2022 (HealthDay News) — While vitamin D got some attention early in the pandemic, it does not reduce the risk of either COVID-19 or other respiratory infections, two new clinical trials found. Both studies, one done in the United K…
Learn MoreTexas Judge Says Obamacare Can’t Require Coverage for Meds That Prevent HIV
THURSDAY, Sept. 8, 2022 (HealthDay News) – Hundreds of thousands of Americans take medications intended to prevent infection with HIV, but a federal judge in Texas ruled Wednesday that a provision in the Affordable Care Act (ACA) that requires free co…
Learn MoreHealth Highlights: Sept. 8, 2022
Too little exercise, too much sitting could raise breast cancer risk. People more likely to engage in physical activity based on their DNA had a 41% lower risk of invasive breast cancer, a new study found. Read moreIn rare 2nd review, FDA panelists ba…
Learn More